Intrinsic Value of S&P & Nasdaq Contact Us

Exicure, Inc. XCUR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.00
+203.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Exicure, Inc. (XCUR) has a negative trailing P/E of -5.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -19.02%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+203.3%).
  • Trailing Earnings Yield -19.02% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $12.00 (+203.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 42/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — XCUR

Valuation Multiples
P/E (TTM)-5.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio6.62
P/S Ratio0.00
EV/EBITDA-2.4
Per Share Data
EPS (TTM)$-0.79
Book Value / Share$0.62
Revenue / Share$0.00
FCF / Share$-1.36
Yields & Fair Value
Earnings Yield-19.02%
Dividend Yield0.00%
Analyst Target$12.00 (+203.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -36.0 -1.25 248.84 587.99 -
2017 -55.5 1.57 30.62 62.92 -
2018 -32.5 -0.34 34.80 6,178.37 -
2019 -31.4 1.94 10.21 636.35 -
2020 -31.3 0.82 12.55 46.45 -
2021 -1.4 -0.01 7.97 -185.43 -
2022 -10.3 0.11 1.78 0.92 -
2023 -1.4 0.00 7.67 0.00 -
2024 -8.6 0.35 12.31 166.76 -
2025 -6.9 0.14 8.69 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-12.88 $1.04M $-16.94M -1635.2%
2017 $-8.37 $9.72M $-11.01M -113.3%
2018 $-16.32 $118K $-22.41M -18994.1%
2019 $-13.68 $1.3M $-26.3M -2029.6%
2020 $-8.49 $16.61M $-24.67M -148.5%
2021 $-21.70 $-483K $-64.1M -
2022 $-0.56 $28.83M $-2.58M -9%
2023 $-2.11 $0.00 $-16.91M -
2024 $-4.75 $500K $-9.7M -1940.2%
2025 $-0.79 $0.00 $-4.95M -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message